xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207669 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207671 | 417 | Table 3 | Positive-Intermediate | true | 434.8 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4316 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ASAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207674 | 417 | Table 3 | Positive-Low | true | 701.8 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207679 | 417 | Table 3 | Positive-High | true | 10.6 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207675 | 417 | Table 3 | Positive-Intermediate | true | 200.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207676 | 417 | Table 3 | Positive-High | true | 5.8 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207678 | 417 | Table 3 | Positive-High | true | 21.5 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207680 | 417 | Table 3 | Positive-High | true | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 4880 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ATAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207677 | 417 | Table 3 | Positive-Intermediate | true | 109.9 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207682 | 417 | Table 3 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207684 | 417 | Table 3 | Positive-High | true | 4.3 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207681 | 417 | Table 3 | Positive-Intermediate | true | 98.1 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207685 | 417 | Table 3 | Positive-High | true | 3.7 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207686 | 417 | Table 3 | Positive-Intermediate | true | 58.9 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 5257 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | AVAKAAAAV | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207683 | 417 | Table 3 | Positive-High | true | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207694 | 417 | Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207700 | 417 | Table 3 | Positive-Low | true | 869.6 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207695 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207698 | 417 | Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207699 | 417 | Table 3 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207697 | 417 | Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 15878 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FFPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207696 | 417 | Table 3 | Positive-Low | true | 666.7 | null | null | null | null | null | null | null | null | null | null | null | null | 3 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207701 | 417 | Table 3 | Positive-High | true | 27.8 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207704 | 417 | Table 3 | Positive-High | true | 5.3 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207707 | 417 | Table 3 | Positive-Intermediate | true | 75.5 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207703 | 417 | Table 3 | Positive-High | true | 24.4 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207706 | 417 | Table 3 | Positive-Intermediate | true | 74.2 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207705 | 417 | Table 3 | Positive-High | true | 3.7 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16274 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FIPSYDFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207702 | 417 | Table 3 | Positive-High | true | 6.6 | null | null | null | null | null | null | null | null | null | null | null | null | 7 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207714 | 417 | Table 2, Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207718 | 417 | Table 2, Table 3 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207710 | 417 | Table 2, Table 3 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207720 | 417 | Table 3, Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207712 | 417 | Table 2, Table 3 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207716 | 417 | Table 2, Table 3 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16428 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FKPSDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207708 | 417 | Table 2, Table 3 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207733 | 417 | Table 2 | Positive-High | true | 2.9 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207735 | 417 | Table 2 | Positive-Intermediate | true | 93.1 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207729 | 417 | Table 2 | Positive-High | true | 5.3 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207730 | 417 | Table 2 | Positive-High | true | 5.3 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207732 | 417 | Table 2 | Positive-High | true | 7.1 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207734 | 417 | Table 2 | Positive-High | true | 17.7 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16809 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPKDYFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207731 | 417 | Table 2 | Positive-High | true | 3.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207737 | 417 | Table 2 | Positive-High | true | 6.2 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207741 | 417 | Table 2 | Positive-High | true | 12.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207740 | 417 | Table 2 | Positive-High | true | 1.443 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207736 | 417 | Table 2 | Positive-High | true | 8.7 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207738 | 417 | Table 2 | Positive-High | true | 1.5 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207739 | 417 | Table 2 | Positive-High | true | 10.8 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16838 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDKFPSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207742 | 417 | Table 2 | Positive-High | true | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207746 | 417 | Table 2 | Positive-Intermediate | true | 56.6 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207744 | 417 | Table 2 | Positive-High | true | 19.6 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207745 | 417 | Table 2 | Positive-High | true | 1.7 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207749 | 417 | Table 2 | Positive-Intermediate | true | 434.8 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207748 | 417 | Table 2 | Positive-Intermediate | true | 92.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207747 | 417 | Table 2 | Positive-High | true | 12.8 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16840 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFKSV | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207743 | 417 | Table 2 | Positive-High | true | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | 4 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207758 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207760 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207761 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207759 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207763 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207757 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16842 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSD | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207762 | 417 | Table 4 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 2 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207765 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207766 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207764 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207767 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207768 | 417 | Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16843 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSF | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207769 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207775 | 417 | Table 4 | Positive-Intermediate | true | 153.4 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207770 | 417 | Table 4 | Positive-High | true | 23.9 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207772 | 417 | Table 4 | Positive-Intermediate | true | 66.7 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207771 | 417 | Table 4 | Positive-High | true | 6.2 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207773 | 417 | Table 4 | Positive-High | true | 22.7 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207774 | 417 | Table 4 | Positive-High | true | 14.3 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16844 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSI | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207776 | 417 | Table 4 | Positive-Intermediate | true | 102.6 | null | null | null | null | null | null | null | null | null | null | null | null | 1 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207787 | 417 | Table 2 | Negative | false | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207777 | 417 | Table 2, Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207788 | 417 | Table 4, Table 2 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207785 | 417 | Table 2, Table 4 | Negative | false | 370.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207781 | 417 | Table 2, Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207779 | 417 | Table 2, Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16845 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSK | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207783 | 417 | Table 2, Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 8 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207790 | 417 | Table 4 | Positive-High | true | 27.8 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207793 | 417 | Table 4 | Positive-High | true | 16.6 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207791 | 417 | Table 4 | Positive-High | true | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207792 | 417 | Table 4 | Positive-High | true | 43.5 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207794 | 417 | Table 4 | Positive-High | true | 48.1 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207795 | 417 | Table 4 | Positive-Intermediate | true | 100.0 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16846 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSL | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207796 | 417 | Table 4 | Positive-Intermediate | true | 459.8 | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207802 | 417 | Table 4 | Positive-Low | true | 2300.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207797 | 417 | Table 4 | Positive-Intermediate | true | 217.4 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207798 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207799 | 417 | Table 4 | Negative | false | 1000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207801 | 417 | Table 4 | Positive-Intermediate | true | 308.4 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207800 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16847 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSP | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207803 | 417 | Table 4 | Negative | false | 4000.0 | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207804 | 417 | Table 4 | Negative | false | 500.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
200136.xml | 200136 | 2022-11-14-08:00 | 11704282 | 2,001 | Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. | Human immunology | J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette | 16848 | null | SequenceMoleculeNoNaturalSource | Peptide, no natural source | FLPSDYFPSQ | 10 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 207807 | 417 | Table 4 | Negative | false | 430.0 | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.